| ■ 영문 제목 : Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00024 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 108 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 과립구-콜로니 자극 인자 (G-CSF) 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (필그라스팀, 페피그라스팀, 리페피그라스팀)와 용도별 시장규모 (종양, 혈액질환, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 과립구-콜로니 자극 인자 (G-CSF) 약물 시장 점유율 - 지역별 과립구-콜로니 자극 인자 (G-CSF) 약물 시장규모 - 주요지역의 종류별 시장규모 (필그라스팀, 페피그라스팀, 리페피그라스팀) - 주요지역의 용도별 시장규모 (종양, 혈액질환, 기타) - 미주의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Amgen, Kyowa Kirin, Chugai Pharmaceutical, Novartis, Teva, Pfizer, Merck, Dong-A Socio, Intas, GenSci, Dr. Reddy, Amoytop, North China Pharmaceutical, SL Pharm, Hayao Group - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs will have significant change from previous year. By the most conservative estimates of global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Filgrastim
Pefigrastim
Lipefigrastim
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Oncology
Blood Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
Kyowa Kirin
Chugai Pharmaceutical
Novartis
Teva
Pfizer
Merck
Dong-A Socio
Intas
GenSci
Dr. Reddy
Amoytop
North China Pharmaceutical
SL Pharm
Hayao Group
1 Scope of the Report 2 Executive Summary 3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Players 4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Filgrastim Table 3. Major Players of Pefigrastim Table 4. Major Players of Lipefigrastim Table 5. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021) Table 8. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021) Table 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Players (2019-2021E) Table 13. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Key Players Head office and Products Offered Table 14. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Regions 2016-2021 Table 19. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country (2016-2021) Table 21. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021) Table 23. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021) Table 25. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Region (2016-2021) Table 27. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021) Table 29. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021) Table 31. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country (2016-2021) Table 33. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021) Table 35. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Table 44. Key Application and Potential Industries of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Table 45. Key Challenges of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Table 46. Key Trends of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Table 47. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share Forecast by Application (2021-2026) Table 53. Amgen Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 54. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 55. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Amgen Main Business Table 57. Amgen Latest Developments Table 58. Kyowa Kirin Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 59. Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 60. Kyowa Kirin Main Business Table 61. Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Kyowa Kirin Latest Developments Table 63. Chugai Pharmaceutical Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 64. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 65. Chugai Pharmaceutical Main Business Table 66. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Chugai Pharmaceutical Latest Developments Table 68. Novartis Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 69. Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 70. Novartis Main Business Table 71. Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Novartis Latest Developments Table 73. Teva Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 74. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 75. Teva Main Business Table 76. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Teva Latest Developments Table 78. Pfizer Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 79. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 80. Pfizer Main Business Table 81. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Pfizer Latest Developments Table 83. Merck Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 84. Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 85. Merck Main Business Table 86. Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Merck Latest Developments Table 88. Dong-A Socio Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 89. Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 90. Dong-A Socio Main Business Table 91. Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Dong-A Socio Latest Developments Table 93. Intas Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 94. Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 95. Intas Main Business Table 96. Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Intas Latest Developments Table 98. GenSci Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 99. GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 100. GenSci Main Business Table 101. GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. GenSci Latest Developments Table 103. Dr. Reddy Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 104. Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 105. Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 106. Dr. Reddy Main Business Table 107. Dr. Reddy Latest Developments Table 108. Amoytop Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 109. Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 110. Amoytop Main Business Table 111. Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 112. Amoytop Latest Developments Table 113. North China Pharmaceutical Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 114. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 115. North China Pharmaceutical Main Business Table 116. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 117. North China Pharmaceutical Latest Developments Table 118. SL Pharm Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 119. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 120. SL Pharm Main Business Table 121. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 122. SL Pharm Latest Developments Table 123. Hayao Group Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors Table 124. Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered Table 125. Hayao Group Main Business Table 126. Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 127. Hayao Group Latest Developments List of Figures Figure 1. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020 Figure 7. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Oncology Figure 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Oncology (2016-2021) & ($ Millions) Figure 9. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Blood Disease Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Blood Disease (2016-2021) & ($ Millions) Figure 11. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Other Figure 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Other (2016-2021) & ($ Millions) Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020 Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Player in 2020 Figure 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Regions (2016-2021) Figure 16. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions) Figure 17. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions) Figure 18. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions) Figure 20. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country in 2020 Figure 21. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020 Figure 22. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020 Figure 23. United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Regions in 2020 Figure 27. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020 Figure 28. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020 Figure 29. China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 33. India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country in 2020 Figure 36. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020 Figure 37. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020 Figure 38. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 39. France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020 Figure 46. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 52. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 53. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 55. United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 56. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 57. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 58. Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 59. China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 60. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 61. Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 63. India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 64. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 65. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 66. France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 67. UK Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 68. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 69. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 70. Spain Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 71. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 72. South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 73. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 74. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장예측 2021년-2026년] (코드 : LPI-2201K00024) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 과립구-콜로니 자극 인자 (G-CSF) 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |